Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CREB5 |
| Upstream (Parents) |
|---|
| (<<) HLF → CREB5 |
| (<<) WT1 → CREB5 |
| (<<) ARNT2 → CREB5 |
| (<<) MAFF → CREB5 |
| (<<) HIF3A → CREB5 |
| (<<) MYCN → CREB5 |
| (<<) EVX1 → CREB5 |
| (<<) ZNF444 → CREB5 |
| (<<) JUN → CREB5 |
| (<<) CEBPA → CREB5 |
| (<<) BCL3 → CREB5 |
| Downstream (Children) |
|---|
| CREB5 → HOXD13 (>>) |
| CREB5 → HOXD3 (>>) |
| CREB5 → ST18 (>>) |
| CREB5 → MYT1 (>>) |
| CREB5 → NKX3-2 (>>) |
| CREB5 → PITX2 (>>) |
| CREB5 → FOXL2 (>>) |
| CREB5 → IRX4 (>>) |
| CREB5 → EMX1 (>>) |
| CREB5 → FOXI1 (>>) |
| CREB5 → HOXC11 (>>) |
| CREB5 → SPI1 (>>) |
| CREB5 → SOX1 (>>) |
| CREB5 → NFIX (>>) |
